Family Medicine
Partner With Us
Advertisement

Gastroenterology

thumb description

January 27, 2025

Enobosarm Combo Cuts Muscle Loss: Study

Investigational drug in combination with weight-loss treatment preserves lean muscle mass in older patients with obesity, showing promising potential for reducing adiposity and achieving greater weight reduction.

Reuters

thumb description

January 24, 2025

Novo Obesity Shot: 22% Weight Loss

Early trial results reveal promising outcomes as Novo Nordisk's next-generation obesity treatment, amycretin, shows potential for significant weight loss in participants.

Reuters

thumb description

January 24, 2025

A1C Benefits Tied to H. pylori Treatment

Researchers evaluated the safety, efficacy, and glycemic benefits of vonoprazan-amoxicillin dual therapy for H. pylori eradication in type 2 diabetes patients.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

January 24, 2025

CDC Freezes Calls, Travel Amid Review

The U.S. Department of Health and Human Services has initiated a broad pause in public communications and travel, disrupting meetings, publications, and research funding approvals affecting human and animal health.

Reuters

thumb description

January 24, 2025

VA Study Maps GLP-1 Effects Across Systems

Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.

Conexiant

thumb description

January 24, 2025

Celiac Disease Tied to Liver Disease Spike

“Celiac disease patients face twice the risk of chronic liver disease compared to the general population, persisting for over 25 years, a new research reported."

Conexiant